ADVISORY, Sept. 15, 2011 (GLOBE NEWSWIRE) -- What: NuPathe Inc. (PATH), a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, will visit the NASDAQ MarketSite in New York City's Times Square.
